𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Repair of DNA interstrand crosslinks may take place at the nuclear matrix

✍ Scribed by Boyko Atanassov; Anastas Gospodinov; Ivaylo Stoimenov; Emil Mladenov; George Russev; Irina Tsaneva; Boyka Anachkova


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
203 KB
Volume
96
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Host cell reactivation assay using Trioxsalen‐crosslinked plasmid pEGFP‐N1 showed that human cells were able to repair Trioxsalen interstrand crosslinks (ICL). To study the mechanism of this repair pathway, cells were transfected with the plasmids pEGFP‐1, which did not contain the promoter of the egfp gene, and with pEGFP‐G^−^, which did not contain the egfp gene. Neither of these plasmids alone was able to express the green fluorescent protein. After cotransfection with the two plasmids, 1%–2% of the cells developed fluorescent signal, which showed that recombination events had taken place in these cells to create DNA constructs containing the promoter and the gene properly aligned. When one or both of the plasmids were crosslinked with Trioxsalen, the recombination rate increased several fold. To identify the nuclear compartment where recombination takes place, cells were transfected with crosslinked pEGFP‐N1 and the amount of plasmid DNA in the different nuclear fractions was determined. The results showed that Trioxsalen crosslinking increased the percentage of matrix attached plasmid DNA in a dose‐dependant way. Immunoblotting experiments showed that after transfection with Trioxsalen crosslinked plasmids the homologous recombination protein Rad51 also associated with the nuclear matrix fraction. These studies provide a model system for investigating the precise molecular mechanisms that appear to couple repair of DNA ICL with nuclear matrix attachment. © 2005 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Binding of nuclear proteins associated w
✍ Amy J. Warren; Michael A. Ihnat; Sara E. Ogdon; Erin E. Rowell; Joshua W. Hamilt 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 304 KB 👁 2 views

Mitomycin C (MMC) is a DNA crosslinking agent from human Xeroderma Pigmentosum (XP) complethat is used in cancer chemotherapy. Unlike the mentation group A and E cell lines, and a Fanconi's DNA crosslinks formed by cisplatin or psoralen, Anemia cell line were also examined. The UV-20 which significa